Antithrombotics in intracerebral hemorrhage in the era of novel agents and antidotes: A review
Journal of Population Therapeutics & Clinical Pharmacology · 2020
DOI: 10.15586/jptcp.v27i2.660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Population Therapeutics & Clinical Pharmacology, 2020. Verfasst von Dimitrios Giakoumettis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Site UNION, Tournai, Belgium. dgiakoumettis@gmail.com. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Intracerebral hemorrhage (ICH)1 is characterized by the pathological accumulation of blood within the brain parenchyma, most commonly associated with hypertension, arteriovenous malformations, or trauma. However, it can also present in patients receiving antithrombotic drugs, either anticoagulants such as acenocoumarol/warfarin-novel oral anticoagulants or antiplatelets, for the prevention and treatment of thromboembolic disease. OBJECTIVE: The purpose of this review is to present current bibliographic data regarding ICH irrespective of the cause, as well as post-hemorrhage use of antithrombotic agents. Moreover, this review attempts to provide guidelines concerning the termination, inversion, and of course resumption of antithrombotic therapy. METHODS AND MATERIALS: We reviewed the most recently presented available data for patients who dealt with intracerebral hemorrhagic events while on antithrombotic agents (due to atrial fibrillation, prosthetic mechanical valves or recent/recurrent deep vein thrombosis). Furthermore, we examined and compared the thromboembolic risk, the bleeding risk, as well as the re-bleeding risk in two groups: patients receiving antithrombotic therapy versus patients not on antithrombotic therapy. CONCLUSION: Antithrombotic therapy is of great importance when indicated, though it does not come without crucial side-effects, such as ICH. Optimal timing of withdrawal, reversal, and resumption of antithrombotic treatment should be determined by a multidisciplinary team consisting of a stroke specialist, a cardiologist, and a neurosurgeon, who will individually approach the needs and risks of each patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L., Site UNION, Tournai, Belgium. dgiakoumettis@gmail.com.
- Department of Cardiology, General Hospital of Athens "G. Gennimatas", Athens, Greece.
- Department of Neurosurgery, Agia Sofia Children's Hospital, Athens, Greece.
- Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens.
- Section of Cardiovascular Medicine, Yale University School of Medicine, CT, USA.
Zitieren
APA
Giakoumettis, D., Vrachatis, D. A., Panagopoulos, D., Loukina, A., Tsitsinakis, G., Apostolopoulou, K., Giannopoulos, G., Giotaki, S. G., Deftereos, S., & Themistocleous, M. S. (2020). Antithrombotics in intracerebral hemorrhage in the era of novel agents and antidotes: A review. Journal of Population Therapeutics & Clinical Pharmacology. https://doi.org/10.15586/jptcp.v27i2.660
Vancouver
Giakoumettis D, Vrachatis DA, Panagopoulos D, Loukina A, Tsitsinakis G, Apostolopoulou K, et al. Antithrombotics in intracerebral hemorrhage in the era of novel agents and antidotes: A review. Journal of Population Therapeutics & Clinical Pharmacology. 2020. doi:10.15586/jptcp.v27i2.660
BibTeX
@article{Giakoumettis2020,
author = {Giakoumettis, Dimitrios and Vrachatis, Dimitrios A and Panagopoulos, Dimitrios and Loukina, Asimina and Tsitsinakis, Georgios and Apostolopoulou, Katerina and Giannopoulos, Georgios and Giotaki, Sotiria G and Deftereos, Spyridon and Themistocleous, Marios S},
title = {Antithrombotics in intracerebral hemorrhage in the era of novel agents and antidotes: A review},
journal = {Journal of Population Therapeutics & Clinical Pharmacology},
year = {2020},
doi = {10.15586/jptcp.v27i2.660}
}
EUVIMED